161 related articles for article (PubMed ID: 21051859)
1. Defining the E-cadherin repressor interactome in epithelial-mesenchymal transition: the PMC42 model as a case study.
Hugo HJ; Kokkinos MI; Blick T; Ackland ML; Thompson EW; Newgreen DF
Cells Tissues Organs; 2011; 193(1-2):23-40. PubMed ID: 21051859
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
[TBL] [Abstract][Full Text] [Related]
3. Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulation.
Hugo HJ; Wafai R; Blick T; Thompson EW; Newgreen DF
BMC Cancer; 2009 Jul; 9():235. PubMed ID: 19604397
[TBL] [Abstract][Full Text] [Related]
4. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
5. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
[TBL] [Abstract][Full Text] [Related]
6. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.
Serrano-Gomez SJ; Maziveyi M; Alahari SK
Mol Cancer; 2016 Feb; 15():18. PubMed ID: 26905733
[TBL] [Abstract][Full Text] [Related]
7. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
8. Cooperation, amplification, and feed-back in epithelial-mesenchymal transition.
García de Herreros A; Baulida J
Biochim Biophys Acta; 2012 Apr; 1825(2):223-8. PubMed ID: 22306657
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the SNAG and SLUG domains of Snail2 in the repression of E-cadherin and EMT induction: modulation by serine 4 phosphorylation.
Molina-Ortiz P; Villarejo A; MacPherson M; Santos V; Montes A; Souchelnytskyi S; Portillo F; Cano A
PLoS One; 2012; 7(5):e36132. PubMed ID: 22567133
[TBL] [Abstract][Full Text] [Related]
10. Cadherins and epithelial-to-mesenchymal transition.
Gheldof A; Berx G
Prog Mol Biol Transl Sci; 2013; 116():317-36. PubMed ID: 23481201
[TBL] [Abstract][Full Text] [Related]
11. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
McCart Reed AE; Kutasovic JR; Vargas AC; Jayanthan J; Al-Murrani A; Reid LE; Chambers R; Da Silva L; Melville L; Evans E; Porter A; Papadimos D; Thompson EW; Lakhani SR; Simpson PT
J Pathol; 2016 Mar; 238(4):489-94. PubMed ID: 26510554
[TBL] [Abstract][Full Text] [Related]
12. Role of Epithelial-Mesenchymal Transition in Tumor Progression.
Gloushankova NA; Zhitnyak IY; Rubtsova SN
Biochemistry (Mosc); 2018 Dec; 83(12):1469-1476. PubMed ID: 30878022
[TBL] [Abstract][Full Text] [Related]
13. Differential role of Snail1 and Snail2 zinc fingers in E-cadherin repression and epithelial to mesenchymal transition.
Villarejo A; Cortés-Cabrera A; Molina-Ortíz P; Portillo F; Cano A
J Biol Chem; 2014 Jan; 289(2):930-41. PubMed ID: 24297167
[TBL] [Abstract][Full Text] [Related]
14. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
[TBL] [Abstract][Full Text] [Related]
15. p38 maintains E-cadherin expression by modulating TAK1-NF-kappa B during epithelial-to-mesenchymal transition.
Strippoli R; Benedicto I; Foronda M; Perez-Lozano ML; Sánchez-Perales S; López-Cabrera M; Del Pozo MÁ
J Cell Sci; 2010 Dec; 123(Pt 24):4321-31. PubMed ID: 21098640
[TBL] [Abstract][Full Text] [Related]
16. The high mobility group A2 protein epigenetically silences the Cdh1 gene during epithelial-to-mesenchymal transition.
Tan EJ; Kahata K; Idås O; Thuault S; Heldin CH; Moustakas A
Nucleic Acids Res; 2015 Jan; 43(1):162-78. PubMed ID: 25492890
[TBL] [Abstract][Full Text] [Related]
17. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
Yi BR; Kim TH; Kim YS; Choi KC
Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
[TBL] [Abstract][Full Text] [Related]
18. Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Bacigalupo ML; Manzi M; Espelt MV; Gentilini LD; Compagno D; Laderach DJ; Wolfenstein-Todel C; Rabinovich GA; Troncoso MF
J Cell Physiol; 2015 Jun; 230(6):1298-309. PubMed ID: 25469885
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.
Rosivatz E; Becker I; Specht K; Fricke E; Luber B; Busch R; Höfler H; Becker KF
Am J Pathol; 2002 Nov; 161(5):1881-91. PubMed ID: 12414534
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
Lee HK; Lee DS; Park JC
BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
